Nguyen Phuong Tram, Ph.D.

Nguyen Phuong Tram, Ph.D.

Expertise: Neuroscience

Email: nguyenphuongtram@tdtu.edu.vn

Web of Science Google Scholar ORCID

Main Research Directions

  • Investigation of Potential Therapeutic Approaches for Neurodegenerative Diseases
  • Studies on the Mechanisms of Glial Cell Function
  • Evaluation of the Pharmacological Effects of Natural Compounds Using Animal Models

Education

  • 2020 – 2023: Ph.D. in Medical Research, University of Tasmania, Australia
  • 2016 – 2018: M.Pharm. (Master of Pharmacy), Kangwon National University, South Korea
  • 2011 – 2015: Bachelor of Science (B.Sc.) in Biotechnology, International University, Ho Chi Minh City, Vietnam

Experience

  • March 2024 – Present: Lecturer, Faculty of Pharmacy, Ton Duc Thang University, Vietnam
  • 2022 – 2023: Research Assistant, Menzies Institute for Medical Research, University of Tasmania, Australia

Publications

  1. Nguyen PT*, Zarghami A*, Makowiecki K*, Stevens N, Ezegbe V, Kyle K, Wang CT, Ly L, De La Rue K, Hinder MR, Johnson L, Rodger J, Cooper S, Cullen CL, Barnett MH, Young KM, Taylor BV (2024). Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS-outcomes of the phase I randomised controlled trial (TAURUS). Multiple Sclerosis Journal – Experimental, Translational and Clinical. *Co-first authors
  2. Krishnamurthy G, Nguyen PT, Tran BN, Phan HT, Brennecke SP, Moses EK, Melton PE (2023). Genomic variation associated with cardiovascular disease progression following preeclampsia: A systematic review. Frontiers in Epidemiology. 3:1221222.
  3. Makowiecki K, Stevens N, Cullen CL, Zarghami A, Nguyen PT, Johnson L, Rodger J, Hinder MR, Barnett M, Young KM, Taylor BV (2021). Safety of low-intensity repetitive transcranial magneTic brAin stimUlation foR people living with mUltiple Sclerosis (TAURUS): study protocol for a randomised controlled trial. Trials. 23: 626.
  4. Nguyen PT*, Dang DK*, Tran HQ, Shin EJ, Jeong JH, Nah SY, Cho MC, Lee YS, Jang CG, Kim HC (2019). Methiopropamine, a methamphetamine analogue, produces neurotoxicity via dopamine receptors. Chemico-Biological Interactions. 305: 134-147. *Co-first authors
  5. Mai HN, Sharma N, Shin EJ, Nguyen BT, Nguyen PT, Jeong JH, Cho EH, Lee YJ, Kim NH, Jang CG, Nabeshima T, Kim HC (2018). Exposure to far-infrared rays attenuates methamphetamine-induced impairment in recognition memory through inhibition of protein kinase Cδ in male mice: Comparison with the antipsychotic clozapine. Journal of Neuroscience Research. 96(7): 1294-1310.
  6. Mai HN, Sharma N, Shin EJ, Nguyen BT, Nguyen PT, Jeong JH, Jang CG, Cho EH, Nah SY, Kim NH, Nabeshima T, Kim HC (2018). Exposure to far-infrared rays attenuates methamphetamine-induced recognition memory impairment via modulation of the muscarinic M1 receptor, Nrf2 and PKC. Neurochemistry International. 116: 63-76.
  7. Nguyen PT*, Shin EJ*, Dang DK, Tran HQ, Jang CG, Jeong JH, Lee YJ, Lee HJ, Lee YS, Yamada K, Nabeshima T, Kim HC (2018). Role of dopamine D1 receptors in 3-fluoromethamphetamine-induced neurotoxicity in mice. Neurochemistry International. 113:69-84. *Co-first authors
  8. Shin EJ, Tran HQ, Nguyen PT, Jeong JH, Nah SY, Jang CG, Nabeshima T, Kim HC (2018). Role of mitochondria in methamphetamine-induced dopaminergic neurotoxicity: Involvement in oxidative stress, neuroinflammation, and pro-apoptosis – A review. Neurochemical Research. 43(1): 66-78.